• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经济评估中的模型校准:七步走方法。

Calibrating models in economic evaluation: a seven-step approach.

机构信息

Department of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK.

出版信息

Pharmacoeconomics. 2011 Jan;29(1):35-49. doi: 10.2165/11584600-000000000-00000.

DOI:10.2165/11584600-000000000-00000
PMID:21142277
Abstract

In economic evaluation, mathematical models have a central role as a way of integrating all the relevant information about a disease and health interventions, in order to estimate costs and consequences over an extended time horizon. Models are based on scientific knowledge of disease (which is likely to change over time), simplifying assumptions and input parameters with different levels of uncertainty; therefore, it is sensible to explore the consistency of model predictions with observational data. Calibration is a useful tool for estimating uncertain parameters, as well as more accurately defining model uncertainty (particularly with respect to the representation of correlations between parameters). Calibration involves the comparison of model outputs (e.g. disease prevalence rates) with empirical data, leading to the identification of model parameter values that achieve a good fit. This article provides guidance on the theoretical underpinnings of different calibration methods. The calibration process is divided into seven steps and different potential methods at each step are discussed, focusing on the particular features of disease models in economic evaluation. The seven steps are (i) Which parameters should be varied in the calibration process? (ii) Which calibration targets should be used? (iii) What measure of goodness of fit should be used? (iv) What parameter search strategy should be used? (v) What determines acceptable goodness-of-fit parameter sets (convergence criteria)? (vi) What determines the termination of the calibration process (stopping rule)? (vii) How should the model calibration results and economic parameters be integrated? The lack of standards in calibrating disease models in economic evaluation can undermine the credibility of calibration methods. In order to avoid the scepticism regarding calibration, we ought to unify the way we approach the problems and report the methods used, and continue to investigate different methods.

摘要

在经济评估中,数学模型作为一种整合疾病和健康干预相关信息的方法具有核心作用,以便在较长时间内估计成本和后果。模型基于对疾病的科学认识(这可能会随时间变化),对具有不同不确定性水平的简化假设和输入参数进行简化;因此,探索模型预测与观察数据的一致性是合理的。校准是估计不确定参数的有用工具,还可以更准确地定义模型不确定性(特别是在表示参数之间的相关性方面)。校准涉及模型输出(例如疾病流行率)与经验数据的比较,从而确定实现良好拟合的模型参数值。本文提供了有关不同校准方法理论基础的指导。校准过程分为七个步骤,讨论了每个步骤的不同潜在方法,重点关注经济评估中疾病模型的特定特征。这七个步骤是:(i)校准过程中应调整哪些参数?(ii)应使用哪些校准目标?(iii)应使用哪种拟合优度度量?(iv)应使用哪种参数搜索策略?(v)应使用什么来确定可接受的拟合优度参数集(收敛标准)?(vi)应使用什么来确定校准过程的终止(停止规则)?(vii)如何整合模型校准结果和经济参数?经济评估中校准疾病模型缺乏标准可能会削弱校准方法的可信度。为了避免对校准的怀疑,我们应该统一我们处理问题的方法并报告使用的方法,并继续研究不同的方法。

相似文献

1
Calibrating models in economic evaluation: a seven-step approach.经济评估中的模型校准:七步走方法。
Pharmacoeconomics. 2011 Jan;29(1):35-49. doi: 10.2165/11584600-000000000-00000.
2
Calibrating models in economic evaluation: a comparison of alternative measures of goodness of fit, parameter search strategies and convergence criteria.校准经济评估模型:拟合优度、参数搜索策略和收敛标准的替代度量方法比较。
Pharmacoeconomics. 2011 Jan;29(1):51-62. doi: 10.2165/11584610-000000000-00000.
3
Identifying best-fitting inputs in health-economic model calibration: a Pareto frontier approach.确定健康经济模型校准中的最佳拟合输入:一种帕累托前沿方法。
Med Decis Making. 2015 Feb;35(2):170-82. doi: 10.1177/0272989X14528382. Epub 2014 May 5.
4
A review and critique of modelling in prioritising and designing screening programmes.对筛查项目的优先级确定与设计中建模方法的综述与批判
Health Technol Assess. 2007 Dec;11(52):iii-iv, ix-xi, 1-145. doi: 10.3310/hta11520.
5
Calibration methods used in cancer simulation models and suggested reporting guidelines.癌症模拟模型中使用的校准方法及建议的报告指南。
Pharmacoeconomics. 2009;27(7):533-45. doi: 10.2165/11314830-000000000-00000.
6
A Review on Calibration Methods of Cancer Simulation Models.癌症模拟模型校准方法综述
medRxiv. 2024 Nov 19:2024.11.18.24317357. doi: 10.1101/2024.11.18.24317357.
7
Generalisability in economic evaluation studies in healthcare: a review and case studies.医疗保健经济评估研究中的可推广性:综述与案例研究
Health Technol Assess. 2004 Dec;8(49):iii-iv, 1-192. doi: 10.3310/hta8490.
8
Calibrating Parameters for Microsimulation Disease Models: A Review and Comparison of Different Goodness-of-Fit Criteria.校准微观模拟疾病模型的参数:不同拟合优度标准的综述与比较
Med Decis Making. 2016 Jul;36(5):652-65. doi: 10.1177/0272989X16636851. Epub 2016 Mar 8.
9
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
10
Bayesian Methods for Calibrating Health Policy Models: A Tutorial.校准健康政策模型的贝叶斯方法:教程
Pharmacoeconomics. 2017 Jun;35(6):613-624. doi: 10.1007/s40273-017-0494-4.

引用本文的文献

1
Discrete-Event Simulation Model for Cancer Interventions and Population Health in R (DESCIPHR): An Open-Source Pipeline.用于R语言中癌症干预与人群健康的离散事件模拟模型(DESCIPHR):一种开源流程
medRxiv. 2025 May 13:2025.05.12.25327470. doi: 10.1101/2025.05.12.25327470.
2
Development and calibration of a mathematical model of HIV outcomes among Rwandan adults: Informing achievement of global targets across sub-populations in Rwanda.卢旺达成年人中艾滋病毒感染结果数学模型的开发与校准:为卢旺达各亚人群实现全球目标提供信息。
PLoS One. 2025 May 14;20(5):e0310662. doi: 10.1371/journal.pone.0310662. eCollection 2025.
3
Calculating epidemiological outcomes from simulated longitudinal data.

本文引用的文献

1
Calibrating models in economic evaluation: a comparison of alternative measures of goodness of fit, parameter search strategies and convergence criteria.校准经济评估模型:拟合优度、参数搜索策略和收敛标准的替代度量方法比较。
Pharmacoeconomics. 2011 Jan;29(1):51-62. doi: 10.2165/11584610-000000000-00000.
2
Interim modelling analysis to validate reported increases in condom use and assess HIV infections averted among female sex workers and clients in southern India following a targeted HIV prevention programme.针对印度南部一项以目标人群为基础的艾滋病预防规划,开展了中期模型分析,以验证所报告的避孕套使用率提高和女性性工作者及嫖客中艾滋病感染减少情况。
Sex Transm Infect. 2010 Feb;86 Suppl 1(Suppl 1):i33-43. doi: 10.1136/sti.2009.038950.
3
从模拟纵向数据计算流行病学结果。
medRxiv. 2025 May 2:2025.04.30.25326766. doi: 10.1101/2025.04.30.25326766.
4
A novel tobacco forecasting model by multiple sociodemographic strata in Australia.澳大利亚多社会人口阶层的新型烟草预测模型。
Int J Epidemiol. 2025 Feb 16;54(2). doi: 10.1093/ije/dyaf038.
5
Calibration of transition probabilities to model survival of adjuvant trastuzumab for early breast cancer in Indonesia.校准转移概率以模拟印度尼西亚早期乳腺癌辅助曲妥珠单抗治疗的生存率。
Int J Technol Assess Health Care. 2025 Mar 26;41(1):e18. doi: 10.1017/S0266462325000157.
6
Using Bayesian evidence synthesis to quantify uncertainty in population trends in smoking behaviour.使用贝叶斯证据综合法量化吸烟行为人群趋势中的不确定性。
Stat Methods Med Res. 2025 Mar;34(3):545-560. doi: 10.1177/09622802241310326. Epub 2025 Feb 12.
7
The economic impact associated with stent retriever selection for the treatment of acute ischemic stroke: a cost-effectiveness analysis of MASTRO I data from a Chinese healthcare system perspective.支架取栓术选择治疗急性缺血性脑卒中的经济影响:基于中国医疗体系视角下 MASTRO I 数据的成本效果分析。
J Comp Eff Res. 2024 Nov;13(11):e240160. doi: 10.57264/cer-2024-0160. Epub 2024 Nov 5.
8
Development and calibration of a mathematical model of HIV outcomes among Rwandan adults: informing equitable achievement of targets in Rwanda.卢旺达成年人中艾滋病毒感染情况数学模型的开发与校准:为卢旺达公平实现目标提供信息
medRxiv. 2024 Sep 7:2024.09.06.24313223. doi: 10.1101/2024.09.06.24313223.
9
A Framework for Assessing the Impact of Outbreak Response Immunization Programs.评估疫情应对免疫规划影响的框架
Diseases. 2024 Apr 4;12(4):73. doi: 10.3390/diseases12040073.
10
Challenges and Opportunities in Interdisciplinary Research and Real-World Data for Treatment Sequences in Health Technology Assessments.在健康技术评估的治疗序列中,跨学科研究和真实世界数据面临的挑战与机遇。
Pharmacoeconomics. 2024 May;42(5):487-506. doi: 10.1007/s40273-024-01363-1. Epub 2024 Apr 1.
Calibration of disease simulation model using an engineering approach.
采用工程学方法对疾病模拟模型进行校准。
Value Health. 2009 Jun;12(4):521-9. doi: 10.1111/j.1524-4733.2008.00484.x. Epub 2009 Jan 12.
4
Calibration of disease simulation model using an engineering approach.采用工程方法对疾病模拟模型进行校准。
Value Health. 2010 Jan-Feb;13(1):157. doi: 10.1111/j.1524-4733.2009.00659.x. Epub 2009 Oct 26.
5
Calibration methods used in cancer simulation models and suggested reporting guidelines.癌症模拟模型中使用的校准方法及建议的报告指南。
Pharmacoeconomics. 2009;27(7):533-45. doi: 10.2165/11314830-000000000-00000.
6
Estimating progression rates for human papillomavirus infection from epidemiological data.从流行病学数据估算人乳头瘤病毒感染的进展率。
Med Decis Making. 2010 Jan-Feb;30(1):84-98. doi: 10.1177/0272989X09336140. Epub 2009 Jun 12.
7
Model-based cost-effectiveness analysis of interventions aimed at preventing medication error at hospital admission (medicines reconciliation).基于模型的旨在预防住院时用药错误(药物重整)干预措施的成本效益分析。
J Eval Clin Pract. 2009 Apr;15(2):299-306. doi: 10.1111/j.1365-2753.2008.01000.x.
8
Uncertainty and validation of health economic decision models.健康经济决策模型的不确定性和验证。
Health Econ. 2010 Jan;19(1):43-55. doi: 10.1002/hec.1444.
9
A hybrid cohort individual sampling natural history model of age-related macular degeneration: assessing the cost-effectiveness of screening using probabilistic calibration.年龄相关性黄斑变性的混合队列个体抽样自然史模型:使用概率校准评估筛查的成本效益。
Med Decis Making. 2009 May-Jun;29(3):304-16. doi: 10.1177/0272989X08327491. Epub 2009 Jan 6.
10
An evidence synthesis approach to estimating Hepatitis C prevalence in England and Wales.一种用于估计英格兰和威尔士丙型肝炎患病率的证据综合方法。
Stat Methods Med Res. 2009 Aug;18(4):361-79. doi: 10.1177/0962280208094691. Epub 2008 Nov 26.